LV12523B - Antitumor antibiotics (ll-e33288 complex) - Google Patents
Antitumor antibiotics (ll-e33288 complex) Download PDFInfo
- Publication number
- LV12523B LV12523B LVP-00-64A LV000064A LV12523B LV 12523 B LV12523 B LV 12523B LV 000064 A LV000064 A LV 000064A LV 12523 B LV12523 B LV 12523B
- Authority
- LV
- Latvia
- Prior art keywords
- par
- und
- nrrl
- des
- mit
- Prior art date
Links
- 239000003242 anti bacterial agent Substances 0.000 title claims abstract description 33
- 229940088710 antibiotic agent Drugs 0.000 title claims description 32
- 230000000259 anti-tumor effect Effects 0.000 title 1
- 238000000855 fermentation Methods 0.000 claims abstract description 75
- 230000004151 fermentation Effects 0.000 claims abstract description 75
- 150000001875 compounds Chemical class 0.000 claims abstract description 53
- 241000187722 Micromonospora echinospora Species 0.000 claims abstract description 44
- 238000004519 manufacturing process Methods 0.000 claims abstract description 14
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 194
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 118
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 108
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 90
- 238000004809 thin layer chromatography Methods 0.000 claims description 68
- 229910052799 carbon Inorganic materials 0.000 claims description 53
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 52
- 229910052757 nitrogen Inorganic materials 0.000 claims description 52
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 46
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 46
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 46
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 45
- 229920006395 saturated elastomer Polymers 0.000 claims description 43
- 150000003839 salts Chemical class 0.000 claims description 40
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 34
- 229910052794 bromium Inorganic materials 0.000 claims description 30
- 239000007788 liquid Substances 0.000 claims description 30
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 29
- 229930195733 hydrocarbon Natural products 0.000 claims description 26
- 150000002430 hydrocarbons Chemical class 0.000 claims description 26
- 238000001556 precipitation Methods 0.000 claims description 26
- 238000000746 purification Methods 0.000 claims description 26
- 239000002904 solvent Substances 0.000 claims description 25
- 239000000203 mixture Substances 0.000 claims description 24
- 239000003960 organic solvent Substances 0.000 claims description 24
- 229910052740 iodine Inorganic materials 0.000 claims description 23
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 22
- 239000000741 silica gel Substances 0.000 claims description 22
- 229910002027 silica gel Inorganic materials 0.000 claims description 22
- 230000003115 biocidal effect Effects 0.000 claims description 17
- 238000001228 spectrum Methods 0.000 claims description 17
- 238000004440 column chromatography Methods 0.000 claims description 15
- 238000000862 absorption spectrum Methods 0.000 claims description 13
- 238000000605 extraction Methods 0.000 claims description 11
- OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 claims description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 8
- 239000011630 iodine Substances 0.000 claims description 8
- 229910052717 sulfur Inorganic materials 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- UREBWPXBXRYXRJ-UHFFFAOYSA-N ethyl acetate;methanol Chemical compound OC.CCOC(C)=O UREBWPXBXRYXRJ-UHFFFAOYSA-N 0.000 claims description 5
- 244000005700 microbiome Species 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 3
- -1 nitrogan Chemical compound 0.000 claims description 3
- 208000035143 Bacterial infection Diseases 0.000 claims description 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims description 2
- 238000000921 elemental analysis Methods 0.000 claims description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 36
- 229910052700 potassium Inorganic materials 0.000 claims 36
- 239000011591 potassium Substances 0.000 claims 36
- 241000187708 Micromonospora Species 0.000 claims 21
- 238000004587 chromatography analysis Methods 0.000 claims 14
- 238000004458 analytical method Methods 0.000 claims 13
- 238000010521 absorption reaction Methods 0.000 claims 12
- 238000003306 harvesting Methods 0.000 claims 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 9
- 239000000499 gel Substances 0.000 claims 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 6
- 239000000377 silicon dioxide Substances 0.000 claims 6
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims 3
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 claims 3
- 229920001817 Agar Polymers 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- 229910019142 PO4 Inorganic materials 0.000 claims 2
- 238000012550 audit Methods 0.000 claims 2
- PGBHMTALBVVCIT-VCIWKGPPSA-N framycetin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CN)O2)N)O[C@@H]1CO PGBHMTALBVVCIT-VCIWKGPPSA-N 0.000 claims 2
- XELZGAJCZANUQH-UHFFFAOYSA-N methyl 1-acetylthieno[3,2-c]pyrazole-5-carboxylate Chemical compound CC(=O)N1N=CC2=C1C=C(C(=O)OC)S2 XELZGAJCZANUQH-UHFFFAOYSA-N 0.000 claims 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 2
- 239000010452 phosphate Substances 0.000 claims 2
- 238000000926 separation method Methods 0.000 claims 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 claims 1
- 239000005695 Ammonium acetate Substances 0.000 claims 1
- 244000201986 Cassia tora Species 0.000 claims 1
- 244000041517 Etlingera elatior Species 0.000 claims 1
- 241000556720 Manga Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 229940043376 ammonium acetate Drugs 0.000 claims 1
- 235000019257 ammonium acetate Nutrition 0.000 claims 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000004927 fusion Effects 0.000 claims 1
- 208000015181 infectious disease Diseases 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 235000020130 leben Nutrition 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- NCAIGTHBQTXTLR-UHFFFAOYSA-N phentermine hydrochloride Chemical compound [Cl-].CC(C)([NH3+])CC1=CC=CC=C1 NCAIGTHBQTXTLR-UHFFFAOYSA-N 0.000 claims 1
- 239000001508 potassium citrate Substances 0.000 claims 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 239000002246 antineoplastic agent Substances 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 24
- 238000010564 aerobic fermentation Methods 0.000 description 20
- 239000007864 aqueous solution Substances 0.000 description 18
- 230000035772 mutation Effects 0.000 description 18
- 238000005481 NMR spectroscopy Methods 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- 230000001376 precipitating effect Effects 0.000 description 3
- 241000124008 Mammalia Species 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- MTELVVZQSTUYNZ-UHFFFAOYSA-L P(=O)(O)(O)[O-].[I+].[K+].P(=O)(O)(O)[O-] Chemical compound P(=O)(O)(O)[O-].[I+].[K+].P(=O)(O)(O)[O-] MTELVVZQSTUYNZ-UHFFFAOYSA-L 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
- C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/29—Micromonospora
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Hydrogenated Pyridines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67203184A | 1984-11-16 | 1984-11-16 | |
| US78706685A | 1985-10-17 | 1985-10-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LV12523A LV12523A (en) | 2000-08-20 |
| LV12523B true LV12523B (en) | 2000-11-20 |
Family
ID=27100668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LVP-00-64A LV12523B (en) | 1984-11-16 | 2000-05-19 | Antitumor antibiotics (ll-e33288 complex) |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0182152B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JPH0774228B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR890001289B1 (cg-RX-API-DMAC7.html) |
| AT (1) | ATE180513T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU589918B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA1291054C (cg-RX-API-DMAC7.html) |
| DE (1) | DE3588213T2 (cg-RX-API-DMAC7.html) |
| DK (1) | DK168388B1 (cg-RX-API-DMAC7.html) |
| EG (1) | EG17709A (cg-RX-API-DMAC7.html) |
| ES (1) | ES8703160A1 (cg-RX-API-DMAC7.html) |
| FI (1) | FI86892C (cg-RX-API-DMAC7.html) |
| GR (1) | GR852725B (cg-RX-API-DMAC7.html) |
| HU (1) | HU195855B (cg-RX-API-DMAC7.html) |
| IL (7) | IL76878A (cg-RX-API-DMAC7.html) |
| LV (1) | LV12523B (cg-RX-API-DMAC7.html) |
| MX (1) | MX9203146A (cg-RX-API-DMAC7.html) |
| NO (1) | NO163574C (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ214114A (cg-RX-API-DMAC7.html) |
| PT (1) | PT81493B (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3440423A1 (de) * | 1984-11-06 | 1986-05-07 | Dr. Karl Thomae Gmbh, 7950 Biberach | Antibiotisches polypeptid, verfahren zu seiner herstellung, dieses polypeptid erzeugender stamm von staphylococcus epidermidis, dieses polypeptid enthaltende zubereitungsformen und seine verwendung zur bekaempfung infektioeser erkrankungen |
| US5024948A (en) * | 1985-10-17 | 1991-06-18 | American Cyanamid Company | Genetic system for micromonospora |
| SG52432A1 (en) * | 1987-01-30 | 1998-09-28 | American Cyanamid Co | Antitumor antibiotics (pseudoaglycone and dihydro derivatives of ll-33228 complex) |
| US4980297A (en) * | 1987-02-27 | 1990-12-25 | Becton, Dickinson And Company | Device for the membrane separation of the components of a liquid sample |
| ATE112172T1 (de) * | 1987-10-30 | 1994-10-15 | American Cyanamid Co | Targetformer von antitumor-methyltrithioagenzien. |
| EP0330874A3 (en) * | 1988-02-29 | 1989-10-18 | American Cyanamid Company | Antibacterial and antitumor agents LL-E33288 epsilon-I and LL-E33288-epsilonBr, with processes and intermediates for producing said agents |
| US4978748A (en) * | 1988-02-29 | 1990-12-18 | American Cyanamid Company | Intermediate and process for producing the antibacterial and antitumor agents LL-E33288ε-I and LL-E33288Epsilon-Br |
| US4996305A (en) * | 1988-02-29 | 1991-02-26 | American Cyanamid Company | Process for producing the antibiotic and antitumor agents LL-E33288.epsilon.ε-Br |
| US4977143A (en) * | 1988-02-29 | 1990-12-11 | American Cyanamid Company | Antibacterial and antitumor agents LL-E33288EPSILON-I and LL-E33288EPSILON-BR |
| EP0342341A3 (en) * | 1988-05-17 | 1991-07-24 | American Cyanamid Company | Process for producing antitumor antibiotic ll-e33288gamma2 |
| IL94540A0 (en) * | 1989-06-29 | 1991-03-10 | American Cyanamid Co | Antibiotic ll-e19085 |
| CN109553646A (zh) * | 2019-01-21 | 2019-04-02 | 浙江海正药业股份有限公司 | 一种纯化卡里奇霉素的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU515150B2 (en) * | 1975-02-18 | 1981-03-19 | Sterling Drug Inc. | Preparation of aminocyclitol antibiotics |
| GR77567B (cg-RX-API-DMAC7.html) * | 1982-08-26 | 1984-09-24 | Lepetit Spa | |
| US4843008A (en) * | 1984-12-24 | 1989-06-27 | Yamanouchi Pharmaceutical Co., Ltd. | Novel microorganisms and a novel process for producing antibiotics |
-
1985
- 1985-10-29 DE DE3588213T patent/DE3588213T2/de not_active Expired - Lifetime
- 1985-10-29 AT AT85113751T patent/ATE180513T1/de not_active IP Right Cessation
- 1985-10-29 IL IL76878A patent/IL76878A/xx not_active IP Right Cessation
- 1985-10-29 EP EP85113751A patent/EP0182152B1/en not_active Expired - Lifetime
- 1985-11-08 NZ NZ214114A patent/NZ214114A/xx unknown
- 1985-11-11 GR GR852725A patent/GR852725B/el unknown
- 1985-11-14 PT PT81493A patent/PT81493B/pt unknown
- 1985-11-14 CA CA000495303A patent/CA1291054C/en not_active Expired - Lifetime
- 1985-11-15 ES ES548953A patent/ES8703160A1/es not_active Expired
- 1985-11-15 AU AU49957/85A patent/AU589918B2/en not_active Expired
- 1985-11-15 DK DK529685A patent/DK168388B1/da not_active IP Right Cessation
- 1985-11-15 HU HU854365A patent/HU195855B/hu unknown
- 1985-11-15 FI FI854510A patent/FI86892C/fi not_active IP Right Cessation
- 1985-11-15 JP JP60255157A patent/JPH0774228B2/ja not_active Expired - Lifetime
- 1985-11-15 KR KR1019850008548A patent/KR890001289B1/ko not_active Expired
- 1985-11-15 NO NO854578A patent/NO163574C/no not_active IP Right Cessation
- 1985-11-17 EG EG731/85A patent/EG17709A/xx active
-
1990
- 1990-02-16 IL IL93421A patent/IL93421A0/xx unknown
- 1990-02-16 IL IL93418A patent/IL93418A0/xx unknown
- 1990-02-16 IL IL93416A patent/IL93416A0/xx unknown
- 1990-02-16 IL IL93420A patent/IL93420A0/xx unknown
- 1990-02-16 IL IL93419A patent/IL93419A0/xx unknown
- 1990-02-16 IL IL93417A patent/IL93417A0/xx unknown
-
1992
- 1992-06-23 MX MX9203146A patent/MX9203146A/es unknown
-
2000
- 2000-05-19 LV LVP-00-64A patent/LV12523B/lv unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1142467A (en) | Production of antibiotic c-15003 pnd | |
| LV12523B (en) | Antitumor antibiotics (ll-e33288 complex) | |
| JPS5910798B2 (ja) | 新しいリフアマイシン類の製造方法 | |
| LU85953A1 (fr) | Compose antibiotique antitumoral | |
| JPS6254433B2 (cg-RX-API-DMAC7.html) | ||
| JPH01112989A (ja) | Ａｂ−００６抗生物質及びその製造方法 | |
| CN108949610B (zh) | 一种链霉菌和以链霉菌产生的angucycline类化合物及其制备与应用 | |
| JPH10130269A (ja) | カルボリン誘導体 | |
| US4550021A (en) | Antitumor antibiotic 81-484 and process for its production | |
| JPS59102398A (ja) | 新規抗生物質およびその製造法 | |
| US3061514A (en) | Antibiotics a116so and a116sa and their fermentative production | |
| JPS625990A (ja) | 抗生物質およびその製造方法 | |
| JPS6210048A (ja) | 新規生理活性物質ｍｈ４３５ | |
| JPH0213677B2 (cg-RX-API-DMAC7.html) | ||
| EP0167935B1 (en) | Anthracycline derivatives, a process for the production thereof, a pharmaceutical composition containing the same and their use as medicaments | |
| US4162938A (en) | Antibiotic compound | |
| JPS59170092A (ja) | 新規抗生物質ｓｓ８２０１ｄ及びその製造法 | |
| JPS6297A (ja) | アントラサイクリン化合物 | |
| JPH09157266A (ja) | 新規抗生物質エポキシキノマイシンａおよびｂとその製造法 | |
| US3557151A (en) | The compound(+)-5'-hydroxygriseofulvin | |
| JPH0331195B2 (cg-RX-API-DMAC7.html) | ||
| EP0260964A2 (en) | New hapalindoles | |
| JPS6135788A (ja) | 生理活性物質ｓｓ２０８４６ａ及びその製造法 | |
| JPS5831920B2 (ja) | Ｆｒ−９０００１２物質 | |
| JPH0767676A (ja) | ４−クロロスレオニンの製造法及び該化合物を含有する農園芸用除草剤 |